Search Results - "ZEYTINOGLU, MELTEM"

Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis by Zeytinoglu, Meltem, Naaman, Sandra C., Dickens, Laura T.

“…Denosumab (DMAB) is a potent antiresorptive treatment used for treatment of osteoporosis and low bone mineral density (BMD) in those at high risk for fracture…”
Get full text

Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program by Nicholls, Stephen J, Tofé, Santiago, le Roux, Carel W, D'Alessio, David A, Wiese, Russell J, Pavo, Imre, Brown, Katelyn, Weerakkody, Govinda J, Zeytinoglu, Meltem, Romera, Irene C

“…Metabolic syndrome is characterized as the co-occurrence of interrelated cardiovascular risk factors, including insulin resistance, hyperinsulinemia, abdominal…”
Get full text

Association of Loneliness With Falls: A Study of Older US Adults Using the National Social Life, Health, and Aging Project by Zeytinoglu, Meltem, Wroblewski, Kristen E., Vokes, Tamara J., Huisingh-Scheetz, Megan, Hawkley, Louise C., Huang, Elbert S.

“…Objectives: Falls represent a significant cause of morbidity and mortality in older adults, and are more common among those living alone. We aimed to determine…”
Get full text

Primary Care Endocrinology in the Adult Woman by Thomas, Celeste C., MD, MS, Zeytinoglu, Meltem, MD, MBA

“…Diabetes mellitus, thyroid disorders, and osteoporosis are endocrine conditions affecting a significant proportion of women presenting to the…”
Get full text

Vertebral fracture assessment: Enhancing the diagnosis, prevention, and treatment of osteoporosis by Zeytinoglu, Meltem, Jain, Rajesh K, Vokes, Tamara J

“…Abstract Osteoporosis is a highly prevalent condition, resulting in significant morbidity and mortality. Nevertheless, it is frequently untreated. Vertebral…”
Get full text

Talking It Out: Helping Our Patients Live Better While Dying by ZEYTINOGLU, Meltem

“…Although dying is an inevitable part of the life cycle, there has been extensive political debate over end-of-life care. Participating in end-of-life care…”
Get full text

Obesity and Breast Cancer Risk: The Oncogenic Implications of Metabolic Dysregulation by Naaman, Sandra C, Shen, Sherry, Zeytinoglu, Meltem, Iyengar, Neil M

“…Breast cancer is increasing in prevalence in parallel with rising rates of obesity worldwide. Obesity is recognized as a leading modifiable risk factor for the…”
Get full text

COMPARED TO INSULIN GLARGINE, TIRZEPATIDE REDUCES THE PREVALENCE OF THE METABOLIC SYNDROME IN PATIENTS WITH TYPE 2 DIABETES AND HIGH CARDIOVASCULAR RISK: POST-HOC ANALYSIS OF SURPASS-4 by Nicholls, Stephen J., D'Alessio, David, Wiese, Russell, Pavo, Imre, Zeytinoglu, Meltem, Romera, Irene, Weerakkody, Govinda j.

Get full text

728-P: Glycemic Variability of Tirzepatide vs. Insulin Degludec in People with Type 2 Diabetes Using Continuous Glucose Monitoring (SURPASS-3 CGM) by BERGENSTAL, RICHARD M., BARTEE, AMY, ZEYTINOGLU, MELTEM, BRAY, ROSS, ALLEN, SHERYL, BROWN, KATELYN

“…Tirzepatide (TZP) is a novel dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist in development for T2D. In a continuous…”
Get full text

Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2) by Frias, Juan P, De Block, Christophe, Brown, Katelyn, Wang, Hui, Thomas, Melissa K, Zeytinoglu, Meltem, Maldonado, Juan M

“…In previous SURPASS studies tirzepatide reduced hemoglobin glycated A1c (HbA1c) and body weight and improved markers of insulin sensitivity and β-cell function…”
Get full text

The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis by Alexander, Jason T., Staab, Erin M., Wan, Wen, Franco, Melissa, Knitter, Alexandra, Skandari, M. Reza, Bolen, Shari, Maruthur, Nisa M., Huang, Elbert S., Philipson, Louis H., Winn, Aaron N., Thomas, Celeste C., Zeytinoglu, Meltem, Press, Valerie G., Tung, Elizabeth L., Gunter, Kathryn, Bindon, Brittany, Jumani, Sanjay, Laiteerapong, Neda

“…Background Previous meta-analyses of the benefits and harms of glucagon-like peptide-1 receptor agonists (GLP1RAs) have been limited to specific outcomes and…”
Get full text

Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis by Alexander, Jason T., Staab, Erin M., Wan, Wen, Franco, Melissa, Knitter, Alexandra, Skandari, M. Reza, Bolen, Shari, Maruthur, Nisa M., Huang, Elbert S., Philipson, Louis H., Winn, Aaron N., Thomas, Celeste C., Zeytinoglu, Meltem, Press, Valerie G., Tung, Elizabeth L., Gunter, Kathryn, Bindon, Brittany, Jumani, Sanjay, Laiteerapong, Neda

“…Background Sodium-glucose cotransporter-2 inhibitors (SGLT2Is) are a recent class of medication approved for the treatment of type 2 diabetes (T2D). Previous…”
Get full text

420-P: Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Systematic Review and Meta-analysis by ALEXANDER, JASON, STAAB, ERIN M., WAN, WEN, FRANCO, MELISSA, KNITTER, ALEXANDRA C., THOMAS, CELESTE C., PRESS, VALERIE G., ZEYTINOGLU, MELTEM, SKANDARI, REZA, GUNTER, KATHRYN E., BINDON, BRITTANY, JUMANI, SANJAY, BOLEN, SHARI D., MARUTHUR, NISA M., HUANG, ELBERT, PHILIPSON, LOUIS H., LAITEERAPONG, NEDA

“…Background: Several large randomized trials suggest GLP-1RAs may reduce mortality in addition to lowering A1c in patients with T2D. Treatment algorithms from…”
Get full text

421-P: Efficacy and Safety of Sodium–Glucose Cotransporter-2 Inhibitors: A Systematic Review and Meta-analysis by ALEXANDER, JASON, STAAB, ERIN M., WAN, WEN, FRANCO, MELISSA, KNITTER, ALEXANDRA C., THOMAS, CELESTE C., PRESS, VALERIE G., ZEYTINOGLU, MELTEM, SKANDARI, REZA, GUNTER, KATHRYN E., BINDON, BRITTANY, JUMANI, SANJAY, BOLEN, SHARI D., MARUTHUR, NISA M., HUANG, ELBERT, PHILIPSON, LOUIS H., LAITEERAPONG, NEDA

“…Background: Several large randomized trials suggest SGLT2Is may reduce mortality in addition to lowering A1c in patients with T2D. Treatment algorithms from…”
Get full text

Clinical, endoscopic, and histologic features of eosinophilic inflammation of the gastrointestinal tract in pediatric liver transplant patients by Parashette, Kalyan Ray, Zeytinoglu, Meltem, Kernek, Kevin, Molleston, Jean P., Subbarao, Girish

“…Immunosuppression during the post‐transplantation period has led to dramatic outcome improvements in PLTR patients. There have been reports describing the…”
Get full text

Diabetes and Aging: Meeting the Needs of a Burgeoning Epidemic in the United States by Zeytinoglu, Meltem, Huang, Elbert S.

“…Abstract-In the United States, one out of every four adults over the age of 65 has diabetes and one half of all adults in this age group are prediabetic,…”
Get full text